A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
Clinical trial NCT02935153 · UNKNOWN
Trial details
- NCT number
- NCT02935153
- Sponsor
- Southwest Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.